$SNY News

Sanofi: An Alluring And Balanced Mix Of Yield And Growth

Sanofi & Teva’s IBD drug prompts long-term clinical remission in Phase IIb trial

Sanofi and ScionxBio partner on mRNA therapies

Sanofi: Why The Market Seems To Be Overpricing Pipeline Risk

ScionxBio Announces Collaboration to Develop Long-Acting xRNA Therapeutics

UEG Week: Teva and Sanofi’s Duvakitug Maintained Long-Term Positive Outcomes in New Phase 2b Data for Ulcerative Colitis and Crohn’s Disease

Teva Pharma And Sanofi Report Duvakitug Maintained Efficacy Through 44 Weeks In Ulcerative Colitis And Crohn's Disease

Enable Injections Announces Approval in Japan for CirCLIQ® Injector based on enFuse® On-Body Delivery System

Press Release: Sanofi breaks ground on new state-of-the-art insulin manufacturing facility in Germany

Press Release: Sanofi breaks ground on new state-of-the-art insulin manufacturing facility in Germany

What Is Sanofi (ENXTPA:SAN) Really Gaining From Wider Canadian Access?

Sanofi and pCPA Sign Letter of Intent for Dupixent® Across Four Indications in Dermatology and Respiratory Care

Sanofi Must Set Record Straight on Rival Flu Shot Under EU Antitrust Deal

Sanofi Inks Letter Of Intent With pan-Canadian Pharmaceutical Alliance For Dupixent For Four Additional Indications

Update: European Commission Accepts Sanofi's Offer to Address Potential Anticompetitive Disparagement of Competing Flu Vaccine

European Commission Accepts Sanofi's Offer to Address Potential Anticompetitive Disparagement of Competing Flu Vaccine

Sanofi: Information concerning the total number of voting rights and shares – September 2026

Press Release : Availability of the aide-mémoire for Q3 2026 results

Why Is Sanofi (ENXTPA:SAN) Reshaping Its Business Around Vaccines And Mature Medicines?

Sanofi (SAN:CA) Presents at Bank of America Global Healthcare Conference 2026 Transcript